Cited 1 times in 
Cited 0 times in 
Aflibercept 2 mg biosimilars-will they lead the Anti-VEGF biosimilar world globally
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Sharma, Ashish | - |
| dc.contributor.author | Woo, Se Joon | - |
| dc.contributor.author | Lee, Christopher Seungkyu | - |
| dc.contributor.author | Kumar, Nilesh | - |
| dc.contributor.author | Parachuri, Nikulaa | - |
| dc.contributor.author | Bandello, Francesco | - |
| dc.contributor.author | Loewenstein, Anat | - |
| dc.contributor.author | Kuppermann, Baruch D. | - |
| dc.date.accessioned | 2025-11-10T07:37:37Z | - |
| dc.date.available | 2025-11-10T07:37:37Z | - |
| dc.date.created | 2025-08-19 | - |
| dc.date.issued | 2025-04 | - |
| dc.identifier.issn | 0950-222X | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/208568 | - |
| dc.language | English | - |
| dc.publisher | Nature Publishing Group | - |
| dc.relation.isPartOf | EYE | - |
| dc.relation.isPartOf | EYE | - |
| dc.title | Aflibercept 2 mg biosimilars-will they lead the Anti-VEGF biosimilar world globally | - |
| dc.type | Article | - |
| dc.contributor.googleauthor | Sharma, Ashish | - |
| dc.contributor.googleauthor | Woo, Se Joon | - |
| dc.contributor.googleauthor | Lee, Christopher Seungkyu | - |
| dc.contributor.googleauthor | Kumar, Nilesh | - |
| dc.contributor.googleauthor | Parachuri, Nikulaa | - |
| dc.contributor.googleauthor | Bandello, Francesco | - |
| dc.contributor.googleauthor | Loewenstein, Anat | - |
| dc.contributor.googleauthor | Kuppermann, Baruch D. | - |
| dc.identifier.doi | 10.1038/s41433-025-03732-2 | - |
| dc.relation.journalcode | J00886 | - |
| dc.identifier.eissn | 1476-5454 | - |
| dc.identifier.pmid | 39972201 | - |
| dc.identifier.url | https://www.nature.com/articles/s41433-025-03732-2 | - |
| dc.contributor.affiliatedAuthor | Lee, Christopher Seungkyu | - |
| dc.identifier.scopusid | 2-s2.0-85219205001 | - |
| dc.identifier.wosid | 001426191000001 | - |
| dc.citation.volume | 39 | - |
| dc.citation.number | 6 | - |
| dc.citation.startPage | 1026 | - |
| dc.citation.endPage | 1027 | - |
| dc.identifier.bibliographicCitation | EYE, Vol.39(6) : 1026-1027, 2025-04 | - |
| dc.identifier.rimsid | 88677 | - |
| dc.type.rims | ART | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalClass | 1 | - |
| dc.type.docType | Editorial Material | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalWebOfScienceCategory | Ophthalmology | - |
| dc.relation.journalResearchArea | Ophthalmology | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.